Photobiomodulation in Oral Lesions Resulting From Anti-neoplastic Prevention
Photobiomodulation With Low Level Laser in the Prevention and Treatment of Oral Lesions (Mucositis, Hyposalivation and Osteonecrosis) Resulting From Anti-neoplastic Treatment With Chemotherapy or Radiotherapy.
Sponsor: University of Santiago de Compostela
A NA clinical study on Head and Neck Cancer and Hyposalivation, this trial is completed. The trial is conducted by University of Santiago de Compostela and has accumulated 11 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Dec 2023 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jun 2023 — Dec 2023 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 6 earlier versions
-
Dec 2022 — Jun 2023 [monthly]
Recruiting NA
-
Mar 2022 — Dec 2022 [monthly]
Recruiting NA
-
Sep 2021 — Mar 2022 [monthly]
Recruiting NA
-
Jun 2021 — Sep 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Mar 2021 — Jun 2021 [monthly]
Not Yet Recruiting NA
-
Feb 2021 — Mar 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Santiago de Compostela
For direct contact, visit the study record on ClinicalTrials.gov .